SPOTLIGHT -
EP. 1: Initial Workup for Differentiated Thyroid Cancer
EP. 2: Molecular Testing in Thyroid Cancer
EP. 3: Moving Toward Personalized Medicine in Advanced DTC
EP. 4: Multidisciplinary Care of Low/Intermediate Risk DTC
EP. 5: Multidisciplinary Care: High-Risk DTC
EP. 6: RAI-Refractory Defined
EP. 7: Systemic Therapy for RAI-Refractory DTC
EP. 8: TKI Therapy for Advanced Thyroid Cancer
EP. 9: Efficacy and Toxicity of Sorafenib in Advanced DTC
EP. 10: Safety and Efficacy of Lenvatinib in Advanced DTC
EP. 11: TKI Dose Adjustment in Advanced DTC
EP. 12: Sequencing in DTC: Lenvatinib and Sorafenib
EP. 13: Emerging Therapies in Differentiated Thyroid Cancer
EP. 14: Teaching Points and Conclusions in DTC
Dr Berkenstock on ADC-Related Ocular Toxicities in Cervical and Ovarian Cancers
Dr Matalonis on the Management of Mirvetuximab Soravtansine-Related Toxicities in FRα+ Ovarian Cancer
Updated EMPOWER-Lung 3 Data Support Frontline Cemiplimab Plus Chemo in Advanced NSCLC
Neoadjuvant Nivolumab Plus Chemotherapy Retains EFS Advantage in Resectable NSCLC
